Results 181 to 190 of about 12,750 (218)

Safety, tolerability, pharmacokinetics, immunogenicity and pharmacodynamics of 9MW1911, an anti-ST2 monoclonal antibody: results from a first-in-human phase 1 study. [PDF]

Front Pharmacol
Zhao Q, Li Q, Wang Y, Li L, Zhao X, Wu N, Fu D, Yin D, Feng J, Hu Z, Guo Y, Chen R.   +11 more
europepmc   +1 more source

Effect of fluvastatin combined with β-receptor-blockers on cardiac function and peripheral blood NF-κB and sST2 in patients with coronary heart disease complicated with heart failure

, 2018
Ai‐Min Lu, Rong Chen, Bao-Bao Liu
openalex   +1 more source

Assessment of soluble sST2 and NTproBNP cardiac markers during end-to-end stimulation of space flight stages on a long radius centrifuge

А. Г. Гончарова, Kirill S. Kireev, Л. Х. Пастушкова, Д. Н. Каширина, И. Н. Гончаров, I. M. Larina   +5 more
openalex   +1 more source

Association of sST2 with cardiovascular disease in maintenance hemodialysis patients: A systematic review and meta-analysis. [PDF]

J Int Med Res
Zhang Z, Yang T, Zhao M, Chen H.
europepmc   +1 more source

Adversarial Defense without <i>Adversarial Defense</i>: Enhancing Language Model Robustness via Instance-level Principal Component Removal. [PDF]

Trans Assoc Comput Linguist
Wang Y, Xiao C, Li Y, Middleton SE, Moubayed NA, Lin C.   +5 more
europepmc   +1 more source

Growth Differentiation Factor-15 as an Emerging Biomarker in Cardiology: Diagnostic and Prognostic Implications. [PDF]

J Pers Med
Lombardi C, Marandola M, Loria V, Urbani A, Baroni S.   +4 more
europepmc   +1 more source

Noninvasive Assessment of Arterial Wall and Soluble ST2 in Patients with Type 2 Diabetes and Coronary Artery Disease. [PDF]

Int J Mol Sci
Radzik E, Schulz M, Przywara-Chowaniec B, Tomasik A.   +3 more
europepmc   +1 more source

Investigation of the effect of quercetin on experimental traumatic cardiac injury in rats. [PDF]

Front Cardiovasc Med
Taysi ME, Demirel ME, Cetinkaya A, Saylan A, Kayis SA, Alisik M.   +5 more
europepmc   +1 more source

Yiqi Huoxue Tongluo decoction combined with conventional medicine therapy: effects on restenosis rates and clinical efficacy in patients with coronary heart disease undergoing percutaneous coronary intervention. [PDF]

Front Cardiovasc Med
Zhao X, Zhang L, Liu Z.
europepmc   +1 more source